Symbol
TELO on Nasdaq
Investment type
Equity / Common Stock, no par value
Latest Disclosed Ownership
1.77M shares
Security Ownership
5.5%

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity ownership in Telomir Pharmaceuticals, Inc. Common Stock, no par value (TELO)

2025-09-18 - John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.77M shares of Telomir Pharmaceuticals, Inc. Common Stock, no par value (TELO). This represents 5.5% percent ownership of the company.